You just read:

Sosei Heptares Notes That a Valid Marketing Authorization Application For QVM149, a Potential New Inhaled Combination Therapy For Asthma, Has Been Filed With the European Medicines Agency

News provided by

Sosei Heptares

May 23, 2019, 19:46 ET